Trends And Challenges In Outsourced Oral Solid Dosage Forms

As drug companies have fewer and fewer new compounds entering their R&D pipelines, outsourcing of development and manufacturing activities for oral solid dosage forms and sterile forms is on the rise. In a recent podcast, Anil Kane, Ph.D., MBA, Global Head of Technical and Scientific Affairs of Formulation at Patheon, discussed trends and significant changes in outsourcing the manufacture and development of solid oral dosage forms.